From: Follow up after IMRT in oral cavity cancer: update
parameters
n (%)
4-y LRC
4-y DMFS
4-y OAS
postop IMRT (R0-1)
99 (62)
80%
86%
79%
postop IMRT, macroscopic disease present
17 (11))
35%
60%
30%
primary IMRT
44 (27)
37%